$XOS
Xos, Inc. Stock $xos

$xos Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000181949323000066 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$4.697M	$8.571M	$36.38M
YoY Change	-33.2%	159.57%	620.6%
Cost Of Revenue	$5.574M	$16.55M	$66.41M
YoY Change	-45.28%	188.51%	796.15%
Gross Profit	-$877.0K	-$7.975M	-$30.03M
YoY Change	-72.2%	227.78%	1171.34%
Gross Profit Margin	-18.67%	-93.05%	-82.55%
Selling, General & Admin	$13.40M	$11.76M	$50.64M
YoY Change	49.3%	12.67%	64.87%
% of Gross Profit
Research & Development	$5.749M	$6.186M	$30.68M
YoY Change	-49.22%	-53.17%	52.81%
% of Gross Profit
Depreciation & Amortization	$1.000M	$872.0K	$2.100M
YoY Change	233.33%	707.41%	185.33%
% of Gross Profit
Operating Expenses	$19.15M	$17.94M	$81.32M
YoY Change	-5.65%	-22.04%	60.1%
Operating Profit	-$20.03M	-$25.92M	-$111.3M
YoY Change	-14.6%	1.84%	109.48%
Interest Expense	-$2.997M	$5.059M	$14.18M
YoY Change	548.7%	-59.8%	-23.48%
% of Operating Profit
Other Income/Expense, Net	-$4.151M	$1.178M	-$4.835M
YoY Change	-5224.69%	-95.15%	-12823.68%
Pretax Income	-$24.33M	-$19.68M	-$73.32M
YoY Change	14.85%	-272.03%	-413.28%
Income Tax	$2.000K	$5.000K	$8.000K
% Of Pretax Income
Net Earnings	-$24.33M	-$19.69M	-$73.33M
YoY Change	14.84%	-272.1%	-413.34%
Net Earnings / Revenue	-518.01%	-229.69%	-201.58%
Basic Earnings Per Share	-$0.14		-$0.44
Diluted Earnings Per Share	-$0.14	-$0.12	-$0.44
COMMON SHARES
Basic Shares Outstanding	169.0M shares	168.0M shares	165.3M shares
Diluted Shares Outstanding	168.8M shares		174.4M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$64.02M	$86.28M	$86.28M
YoY Change	-37.01%	-22.16%	-24.06%
Cash & Equivalents	$36.49M	$35.63M	$35.63M
Short-Term Investments	$27.53M	$50.65M	$50.65M
Other Short-Term Assets	$7.344M	$11.14M	$11.14M
YoY Change	-57.8%	-38.43%	-38.43%
Inventory	$57.01M	$57.54M	$57.54M
Prepaid Expenses
Receivables	$6.970M	$8.238M	$8.238M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$136.5M	$163.2M	$163.2M
YoY Change	-19.43%	-1.66%	-1.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.92M	$25.14M	$25.14M
YoY Change	32.78%	238.49%	238.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$1.821M	$1.599M	$1.599M
YoY Change	259.88%	216.01%	216.01%
Total Long-Term Assets	$25.75M	$26.74M	$26.74M
YoY Change	-44.74%	-57.39%	-57.39%
TOTAL ASSETS
Total Short-Term Assets	$136.5M	$163.2M	$163.2M
Total Long-Term Assets	$25.75M	$26.74M	$26.74M
Total Assets	$162.2M	$189.9M	$189.9M
YoY Change	-24.89%	-16.95%	-16.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.533M	$2.896M	$2.896M
YoY Change	-55.51%	-71.39%	-71.39%
Accrued Expenses	$7.232M	$7.782M	$9.312M
YoY Change	604.87%	80.85%	132.97%
Deferred Revenue	$764.0K	$721.0K
YoY Change	-90.59%	-19.8%
Short-Term Debt	$2.824M	$2.065M	$0.00
YoY Change
Long-Term Debt Due	$21.76M	$26.85M	$26.85M
YoY Change	4314.4%	5470.33%	5470.33%
Total Short-Term Liabilities	$40.83M	$45.77M	$45.77M
YoY Change	106.25%	186.34%	186.34%
LONG-TERM LIABILITIES
Long-Term Debt	$23.44M	$30.87M	$30.87M
YoY Change	1420.23%	1836.64%	1836.64%
Other Long-Term Liabilities	$10.47M	$11.00M	$1.225M
YoY Change	-74.61%	-70.06%	-96.67%
Total Long-Term Liabilities	$10.47M	$11.00M	$32.10M
YoY Change	-75.52%	-71.3%	-16.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.83M	$45.77M	$45.77M
Total Long-Term Liabilities	$10.47M	$11.00M	$32.10M
Total Liabilities	$72.46M	$77.86M	$77.86M
YoY Change	15.83%	43.36%	43.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$101.7M	-$77.42M
YoY Change	302.5%	1791.47%
Common Stock	$17.00K	$17.00K
YoY Change	6.25%	6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$89.75M	$112.1M	$112.1M
YoY Change
Total Liabilities & Shareholders Equity	$162.2M	$189.9M	$189.9M
YoY Change	-24.89%	-16.95%	-16.95%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$24.33M	-$19.69M	-$73.33M
YoY Change	14.84%	-272.1%	-413.34%
Depreciation, Depletion And Amortization	$1.000M	$872.0K	$2.100M
YoY Change	233.33%	707.41%	185.33%
Cash From Operating Activities	-$15.33M	-$22.36M	-$128.0M
YoY Change	-51.04%	-37.46%	43.95%
INVESTING ACTIVITIES
Capital Expenditures	$253.0K	$2.215M	$14.11M
YoY Change	-91.56%	-240.9%	187.14%
Acquisitions
YoY Change
Other Investing Activities	$23.07M	$9.410M	$96.82M
YoY Change	-23.5%	-106.26%	-164.45%
Cash From Investing Activities	$22.81M	$7.195M	$82.71M
YoY Change	-15.99%	-104.74%	-153.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$4.310M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$9.672M	4.373M	$64.75M
YoY Change	5243.65%	-770.71%	-74.39%
NET CHANGE
Cash From Operating Activities	-$15.33M	-22.36M	-$128.0M
Cash From Investing Activities	$22.81M	7.195M	$82.71M
Cash From Financing Activities	-$9.672M	4.373M	$64.75M
Net Change In Cash	-$2.186M	-10.80M	$19.50M
YoY Change	-49.54%	-94.26%	121.15%
FREE CASH FLOW
Cash From Operating Activities	-$15.33M	-$22.36M	-$128.0M
Capital Expenditures	$253.0K	$2.215M	$14.11M
Free Cash Flow	-$15.58M	-$24.58M	-$142.1M
YoY Change	-54.58%	-28.11%	51.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001819493
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#GainLossOnDerivativeInstrumentsNetPretax
CY2022	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#GainLossOnDerivativeInstrumentsNetPretax
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	169012203	shares
CY2022Q2	dei	Entity Public Float EntityPublicFloat	110700000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3034000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3353000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	94696000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	30883000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17850000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	165958000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	7426000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54816000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1599000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	506000	usd
CY2022Q4	us-gaap	Assets Assets	189936000	usd
CY2021Q4	us-gaap	Assets Assets	228706000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2896000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10122000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	26849000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	405000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15616000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5861000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45766000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15983000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	19870000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2022Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	564000	usd
CY2021Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	29240000	usd
CY2022Q4	xos	Warrants And Rights Outstanding Noncurrent WarrantsAndRightsOutstandingNoncurrent	661000	usd
CY2021Q4	xos	Warrants And Rights Outstanding Noncurrent WarrantsAndRightsOutstandingNoncurrent	7496000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11000000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1594000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	77861000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	54313000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	168817000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	168817000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163137000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163137000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	190215000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178851000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-77418000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4093000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-739000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-381000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	112075000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174393000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	189936000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	228706000	usd
CY2022	us-gaap	Revenues Revenues	36376000	usd
CY2021	us-gaap	Revenues Revenues	5048000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	66405000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	7410000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-30029000	usd
CY2021	us-gaap	Gross Profit GrossProfit	-2362000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41093000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27197000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30679000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20077000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-111348000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-53155000	usd
CY2022	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	usd
CY2021	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	379000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14104000	usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	8000	usd
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	2000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-73325000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23401000	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-358000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-381000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-73683000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23020000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165253000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105568000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174382000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107786000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2762000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7862000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-27197000	usd
CY2021	xos	Temporary Equity Shares Subscribed But Unissued Subscriptions Receivable Payment TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivablePayment	2430000	usd
CY2021	xos	Adjustments To Additional Paid In Capital Payment Of Temporary Equity Subscription Receivable AdjustmentsToAdditionalPaidInCapitalPaymentOfTemporaryEquitySubscriptionReceivable	379000	usd
CY2021	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	49518000	shares
CY2021	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	66701000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1658000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	335000	usd
CY2021	xos	Temporary Equity Stock Issued During Period Shares Preferred Stock Warrant Exercised TemporaryEquityStockIssuedDuringPeriodSharesPreferredStockWarrantExercised	625000	shares
CY2021	xos	Temporary Equity Stock Issued During Period Value Preferred Stock Warrant Exercised TemporaryEquityStockIssuedDuringPeriodValuePreferredStockWarrantExercised	2715000	usd
CY2021	xos	Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	-52905000	shares
CY2021	xos	Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-79708000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	79772000	usd
CY2022	xos	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	55424000	usd
CY2021	xos	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	20721000	usd
CY2021	xos	Adjustments To Additional Paid In Capital Warrants Recognized In Reverse Recapitalization AdjustmentsToAdditionalPaidInCapitalWarrantsRecognizedInReverseRecapitalization	17891000	usd
CY2021	xos	Adjustments To Additional Paid In Capital Recognition Of Derivative Instrument Contingent Consideration Liability AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeInstrumentContingentConsiderationLiability	101744000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23020000	usd
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174393000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5313000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	449000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2123000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4372000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-73683000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	112075000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-73325000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23401000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	2065000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	736000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1566000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2577000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2022	xos	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	1338000	usd
CY2021	xos	Amortization Of Insurance Premiums AmortizationOfInsurancePremiums	0	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	5661000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1004000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	14184000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	18498000	usd
CY2022	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-28682000	usd
CY2021	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-72505000	usd
CY2022	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	usd
CY2021	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	379000	usd
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	0	usd
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-14104000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-147000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	1000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5222000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1658000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1368000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-364000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4942000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2973000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	31285000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29969000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6413000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17794000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1093000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	506000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7268000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9009000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	6462000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2696000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-127960000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-88895000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14113000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4915000	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	152651000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	96823000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2423000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	82710000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-155143000	usd
CY2022	xos	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	usd
CY2021	xos	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	20721000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	196000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	31757000	usd
CY2022	xos	Proceeds From Collection Of Temporary Equity Subscription Receivable ProceedsFromCollectionOfTemporaryEquitySubscriptionReceivable	0	usd
CY2021	xos	Proceeds From Collection Of Temporary Equity Subscription Receivable ProceedsFromCollectionOfTemporaryEquitySubscriptionReceivable	2430000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2715000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	54300000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	403000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	3627000	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1562000	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	usd
CY2022	xos	Proceeds From Equipment Financing Financing Activities ProceedsFromEquipmentFinancingFinancingActivities	6312000	usd
CY2021	xos	Proceeds From Equipment Financing Financing Activities ProceedsFromEquipmentFinancingFinancingActivities	0	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1392000	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	444000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	449000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	335000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4310000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64749000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252855000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19499000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8817000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19176000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10359000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38675000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19176000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35631000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16142000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3044000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3034000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3034000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38675000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19176000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	42000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022Q1	xos	Operating Lease Right Of Use Asset And Operating Lease Liability OperatingLeaseRightOfUseAssetAndOperatingLeaseLiability	7682000	usd
CY2021Q4	xos	Operating Lease Right Of Use Asset And Operating Lease Liability OperatingLeaseRightOfUseAssetAndOperatingLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	437000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	xos	Conversion Of Interest Payable On Convertible Debentures ConversionOfInterestPayableOnConvertibleDebentures	122000	usd
CY2021	xos	Conversion Of Interest Payable On Convertible Debentures ConversionOfInterestPayableOnConvertibleDebentures	0	usd
CY2022	xos	Conversion Of Convertible Debentures To Common Stock ConversionOfConvertibleDebenturesToCommonStock	2000000	usd
CY2021	xos	Conversion Of Convertible Debentures To Common Stock ConversionOfConvertibleDebenturesToCommonStock	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	2453000	usd
CY2022	xos	Fair Value Adjustment Of Related Party Debt At Conversion FairValueAdjustmentOfRelatedPartyDebtAtConversion	0	usd
CY2021	xos	Fair Value Adjustment Of Related Party Debt At Conversion FairValueAdjustmentOfRelatedPartyDebtAtConversion	3763000	usd
CY2022	xos	Debt Conversion Converted Instrument Interest Payable Amount DebtConversionConvertedInstrumentInterestPayableAmount	0	usd
CY2021	xos	Debt Conversion Converted Instrument Interest Payable Amount DebtConversionConvertedInstrumentInterestPayableAmount	34918000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	21540000	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	79708000	usd
CY2022	xos	Assumption Of Public And Private Warrants AssumptionOfPublicAndPrivateWarrants	0	usd
CY2021	xos	Assumption Of Public And Private Warrants AssumptionOfPublicAndPrivateWarrants	17891000	usd
CY2022	xos	Recognition Of Earn Out Shares Liability RecognitionOfEarnOutSharesLiability	0	usd
CY2021	xos	Recognition Of Earn Out Shares Liability RecognitionOfEarnOutSharesLiability	101744000	usd
CY2022	xos	Transaction Costs Relating To Reverse Merger Offset Against Additional Paid In Capital TransactionCostsRelatingToReverseMergerOffsetAgainstAdditionalPaidInCapital	0	usd
CY2021	xos	Transaction Costs Relating To Reverse Merger Offset Against Additional Paid In Capital TransactionCostsRelatingToReverseMergerOffsetAgainstAdditionalPaidInCapital	55424000	usd
CY2021Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	216700000	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	86300000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenues and expenses during the reporting periods. The areas with significant estimates and judgments include, among others, inventory valuation, incremental borrowing rates for assessing operating and financing lease liabilities, useful lives of property and equipment, contingent earn-out shares liability, stock-based compensation, valuation of convertible debt and related embedded derivatives, common stock warrant liability and product warranty liability. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to the Company’s financial statements.
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain prior p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">eriod balances have been reclassified to conform to the current period presentation in the consolidated financial statements and the accompanying notes, including (i) presenting equipment leases as part of other current and non-current liabilities and (ii) classification of amounts comprising p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">repaid expenses and other current assets</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as well as other current liabilities as included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="#idc6f318c3e4945f2ab910fdff8ee81d6_118" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Note 5 — Selected Balance Sheet Data</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Additionally, the Company reclassified depreciation expense to general and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. These reclassifications have no effect on previously reported total assets, total liabilities or net loss.</span>
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	0	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	177000	usd
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	1300000	usd
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	usd
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	usd
CY2020Q4	xos	Safe Note Percentage Of Price Per Share In Calculation For Conversion Into Temporary Equity SAFENotePercentageOfPricePerShareInCalculationForConversionIntoTemporaryEquity	0.80
CY2021Q1	xos	Proceeds From The Conversion Of Safe Notes ProceedsFromTheConversionOfSAFENotes	620000	usd
CY2021Q1	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	76471	shares
CY2021	us-gaap	Advertising Expense AdvertisingExpense	400000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such accounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2022, one customer accounted for 42% of the Company’s revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. During the year ended December 31, 2021, three customers accounted for 10%, 38%, and 46% </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of the Company’s revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. As of December 31, 2022, two customers accounted for 22% and 12% of the Company’s accounts receivable. As of December 31, 2021, two customers accounted for 53% and 38% of the Company’s accounts receivable.</span></div>
CY2022	xos	Defined Contribution Plan Auto Enrollment Contributions Per Employee Percent DefinedContributionPlanAutoEnrollmentContributionsPerEmployeePercent	0.03
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	50600000	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	149500000	usd
CY2022	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1715000	usd
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	161000	usd
CY2022	us-gaap	Revenues Revenues	36376000	usd
CY2021	us-gaap	Revenues Revenues	5048000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	5700000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1000000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	40271000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	19323000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4618000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	10659000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12651000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	901000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	57540000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	30883000	usd
CY2022Q4	xos	Prepaid Inventory PrepaidInventory	2372000	usd
CY2021Q4	xos	Prepaid Inventory PrepaidInventory	7303000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1589000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	5916000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	2289000	usd
CY2021Q4	us-gaap	Financing Receivable Unamortized Purchase Premium Discount FinancingReceivableUnamortizedPurchasePremiumDiscount	0	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2783000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1850000	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1848000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8100000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17850000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7782000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4303000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	721000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	899000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	1099000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	177000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	303000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	482000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2065000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1530000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2116000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15616000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5861000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	784000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	942000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1594000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5174000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1861000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2552000	usd
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year One LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearOne	4413000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1907000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2467000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4100000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11000000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1594000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6555000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7979000	usd
CY2022Q4	xos	Operating Lease Right Of Use Asset And Finance Lease Right Of Use Asset After Accumulated Amortization OperatingLeaseRightOfUseAssetAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization	14534000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1530000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2116000	usd
CY2022Q4	xos	Operating Lease Liability Current And Finance Lease Liability Current OperatingLeaseLiabilityCurrentAndFinanceLeaseLiabilityCurrent	3646000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5174000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4100000	usd
CY2022Q4	xos	Operating Lease Liability Noncurrent And Finance Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrentAndFinanceLeaseLiabilityNoncurrent	9274000	usd
CY2022Q4	xos	Operating Lease Liability And Finance Lease Liability OperatingLeaseLiabilityAndFinanceLeaseLiability	12920000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2022	us-gaap	Lease Cost LeaseCost	2500000	usd
CY2021	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	300000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	848000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	222000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	428000	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	52000	usd
CY2022	xos	Finance Lease Right Of Use Asset Amortization And Finance Lease Interest Payment On Liability FinanceLeaseRightOfUseAssetAmortizationAndFinanceLeaseInterestPaymentOnLiability	1276000	usd
CY2021	xos	Finance Lease Right Of Use Asset Amortization And Finance Lease Interest Payment On Liability FinanceLeaseRightOfUseAssetAmortizationAndFinanceLeaseInterestPaymentOnLiability	274000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1734000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	437000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.069
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year Two LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearTwo	4374000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1962000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6116000	usd
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	2077000	usd
CY2021Q4	xos	Operating Leases And Capital Leases Future Minimum Payments Due OperatingLeasesAndCapitalLeasesFutureMinimumPaymentsDue	8193000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1362000	usd
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year Three LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearThree	3324000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1631000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	498000	usd
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year Four LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearFour	2129000	usd
CY2022Q4	xos	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	114000	usd
CY2022Q4	xos	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	157000	usd
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidAfterYearFour	271000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7475000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7036000	usd
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability Payment Due LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityPaymentDue	14511000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	771000	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	820000	usd
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityUndiscountedExcessAmount	1591000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6704000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	6216000	usd
CY2022Q4	xos	Lessee Operating Lease Liability And Finance Lease Liability LesseeOperatingLeaseLiabilityAndFinanceLeaseLiability	12920000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1167000	usd
CY2021Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	482000	usd
CY2021Q4	xos	Operating Leases Future Minimum Payments Remainder Of Fiscal Year And Capital Lease Obligations Current OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYearAndCapitalLeaseObligationsCurrent	1649000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1158000	usd
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	442000	usd
CY2021Q4	xos	Operating Leases And Capital Leases Future Minimum Payments Due In Two Years OperatingLeasesAndCapitalLeasesFutureMinimumPaymentsDueInTwoYears	1600000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1192000	usd
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	386000	usd
CY2021Q4	xos	Operating Leases And Capital Leases Future Minimum Payments Due In Three Years OperatingLeasesAndCapitalLeasesFutureMinimumPaymentsDueInThreeYears	1578000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1228000	usd
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	401000	usd
CY2021Q4	xos	Operating Leases And Capital Leases Future Minimum Payments Due In Four Years OperatingLeasesAndCapitalLeasesFutureMinimumPaymentsDueInFourYears	1629000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1265000	usd
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	339000	usd
CY2021Q4	xos	Operating Leases And Capital Leases Future Minimum Payments Due In Five Years OperatingLeasesAndCapitalLeasesFutureMinimumPaymentsDueInFiveYears	1604000	usd
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	106000	usd
CY2021Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	27000	usd
CY2021Q4	xos	Operating Leases And Capital Leases Future Minimum Payments Due Thereafter OperatingLeasesAndCapitalLeasesFutureMinimumPaymentsDueThereafter	133000	usd
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	xos	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.956440
CY2021Q3	xos	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	142584621	shares
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	19600000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	196000000	usd
CY2021Q3	xos	Sale Of Stock Consideration Not Funded SaleOfStockConsiderationNotFunded	4000000	usd
CY2021Q3	xos	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	44200000	usd
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	101700000	usd
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17900000	usd
CY2021	xos	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	76145000	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	196000000	usd
CY2021	xos	Payments Of Reverse Recapitalization Underwriters Fees PaymentsOfReverseRecapitalizationUnderwritersFees	24285000	usd
CY2021	xos	Payments Of Reverse Recapitalization Other Transaction Costs PaymentsOfReverseRecapitalizationOtherTransactionCosts	31139000	usd
CY2021	xos	Reverse Recapitalization Net ReverseRecapitalizationNet	216721000	usd
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	19600000	shares
CY2021	xos	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	162184621	shares
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	16200000	shares
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability Fair Value Disclosure DerivativeInstrumentContingentConsiderationLiabilityFairValueDisclosure	101700000	usd
CY2022Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	600000	usd
CY2021Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	29200000	usd
CY2022	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-28700000	usd
CY2021	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-72500000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	35000000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	20000000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	15000000	usd
CY2022Q3	xos	Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2000000	usd
CY2022Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P30D
CY2022	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.10
CY2022	xos	Convertible Debt Remaining Percent ConvertibleDebtRemainingPercent	0.075
CY2022	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	2.4733
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.97
CY2022Q4	xos	Class Of Warrant Or Right Share Price Redemption Trigger ClassOfWarrantOrRightSharePriceRedemptionTrigger	0.50
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	400000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2000000	usd
CY2022Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	20000000	usd
CY2022Q4	xos	Debt Instrument Additional Issuance Of Convertible Of Debt DebtInstrumentAdditionalIssuanceOfConvertibleOfDebt	20000000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.100
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10D
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	2.3817
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10D
CY2022Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	20000000	usd
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	usd
CY2020Q4	xos	Safe Note Price Per Share In Calculation For Conversion Into Temporary Equity SAFENotePricePerShareInCalculationForConversionIntoTemporaryEquity	30	usd
CY2020Q4	xos	Safe Note Percentage Of Price Per Share In Calculation For Conversion Into Temporary Equity SAFENotePercentageOfPricePerShareInCalculationForConversionIntoTemporaryEquity	0.80
CY2021Q1	xos	Proceeds From The Conversion Of Safe Notes ProceedsFromTheConversionOfSAFENotes	600000	usd
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	usd
CY2021Q1	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	76471	shares
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	51387000	usd
CY2022	xos	Debt Securities Available For Sale Unrealized Gain Current DebtSecuritiesAvailableForSaleUnrealizedGainCurrent	0	usd
CY2022	xos	Debt Securities Available For Sale Unrealized Loss Current DebtSecuritiesAvailableForSaleUnrealizedLossCurrent	739000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	50648000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	94782000	usd
CY2021	xos	Debt Securities Available For Sale Unrealized Gain Current DebtSecuritiesAvailableForSaleUnrealizedGainCurrent	1000	usd
CY2021	xos	Debt Securities Available For Sale Unrealized Loss Current DebtSecuritiesAvailableForSaleUnrealizedLossCurrent	87000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	94696000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	55111000	usd
CY2021	xos	Debt Securities Available For Sale Unrealized Gain Noncurrent DebtSecuritiesAvailableForSaleUnrealizedGainNoncurrent	0	usd
CY2021	xos	Debt Securities Available For Sale Unrealized Loss Noncurrent DebtSecuritiesAvailableForSaleUnrealizedLossNoncurrent	295000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54816000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	1789000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	48859000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	737000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	50648000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	739000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	149512000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	381000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	149512000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	381000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	147000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	1000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	51387000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	50648000	usd
CY2022	xos	Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Weighted Average Contractual Maturity Period DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWeightedAverageContractualMaturityPeriod	P0Y3M18D
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	94782000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	94696000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	55111000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	54816000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	149893000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	149512000	usd
CY2021	xos	Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Weighted Average Contractual Maturity Period DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWeightedAverageContractualMaturityPeriod	P0Y9M18D
CY2022Q4	xos	Capital Stock Shares Authorized CapitalStockSharesAuthorized	1010000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	xos	Common Stock Voting Rights Number Of Votes CommonStockVotingRightsNumberOfVotes	1	vote
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1809515	shares
CY2022	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	4300000	usd
CY2022	xos	Sale Of Stock Remaining Commitment Amount Available SaleOfStockRemainingCommitmentAmountAvailable	120700000	usd
CY2022	xos	Class Of Warrant Or Right Fair Market Value Threshold Consecutive Trading Days Ending On Third Trading Day Prior To Notice Of Redemption ClassOfWarrantOrRightFairMarketValueThresholdConsecutiveTradingDaysEndingOnThirdTradingDayPriorToNoticeOfRedemption	P10D
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	319411	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.50
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2021Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2700000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1572451	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1838759	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.02
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.02
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5756797	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	144712	shares
CY2022	xos	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	0.04
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.03
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	121596	shares
CY2022	xos	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	0.03
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.03
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1572451	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.02
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	670451	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	965454	shares
CY2022	xos	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	0.02
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.02
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y11M19D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	411741	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	700000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5800000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5200000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1700000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5222000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1658000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	13500000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M3D
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	9283000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	3378000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	23052000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	8897000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	4471000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	1471000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	18581000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	7426000	usd
CY2022	us-gaap	Depreciation Depreciation	2100000	usd
CY2021	us-gaap	Depreciation Depreciation	700000	usd
CY2022Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	1820000	usd
CY2022Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	1300000	usd
CY2022Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	1300000	usd
CY2022Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	1300000	usd
CY2022Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	1300000	usd
CY2022Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	1300000	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	8320000	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	100000	usd
CY2020	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	100000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	400000	usd
CY2022Q4	xos	Notes Payable Related Parties Interest Rate Stated Percentage NotesPayableRelatedPartiesInterestRateStatedPercentage	0.0238
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	400000	usd
CY2021	xos	Notes Payable Related Parties Accrued Interest NotesPayableRelatedPartiesAccruedInterest	15000	usd
CY2021	xos	Notes Payable Related Parties Number Of Notes Payable Converted NotesPayableRelatedPartiesNumberOfNotesPayableConverted	34	note_payable
CY2021Q4	xos	Temporary Equity Stock Issued During Period To Related Parties Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodToRelatedPartiesValueConversionOfConvertibleSecurities	18900000	usd
CY2021Q4	xos	Temporary Equity Stock Issued During Period To Related Parties Shares Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodToRelatedPartiesSharesConversionOfConvertibleSecurities	19664000	usd
CY2021Q4	us-gaap	Due To Employees Current And Noncurrent DueToEmployeesCurrentAndNoncurrent	100000	usd
CY2022Q4	us-gaap	Due To Employees Current And Noncurrent DueToEmployeesCurrentAndNoncurrent	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-73317000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	23403000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-73317000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23403000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0093
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0011
CY2022	xos	Effective Income Tax Rate Reconciliation Adjustments On Earnout Interests Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnEarnoutInterestsLiabilityPercent	0.0822
CY2021	xos	Effective Income Tax Rate Reconciliation Adjustments On Earnout Interests Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnEarnoutInterestsLiabilityPercent	-0.6506
CY2022	xos	Effective Income Tax Rate Reconciliation Adjustments On Derivative Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnDerivativeLiabilityPercent	0.0196
CY2021	xos	Effective Income Tax Rate Reconciliation Adjustments On Derivative Liability Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnDerivativeLiabilityPercent	-0.1660
CY2022	xos	Effective Income Tax Rate Reconciliation Adjustments On Convertible Notes Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnConvertibleNotesPercent	0
CY2021	xos	Effective Income Tax Rate Reconciliation Adjustments On Convertible Notes Percent EffectiveIncomeTaxRateReconciliationAdjustmentsOnConvertibleNotesPercent	0.1266
CY2022	xos	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	0
CY2021	xos	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	-0.2191
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.0310
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0318
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1041
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.2033
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4479
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.9200
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0102
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0132
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0001
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0001
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39061000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18649000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	5622000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	1180000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5937000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2236000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2376000	usd
CY2022Q4	xos	Deferred Tax Assets Fair Value Adjustments DeferredTaxAssetsFairValueAdjustments	199000	usd
CY2021Q4	xos	Deferred Tax Assets Fair Value Adjustments DeferredTaxAssetsFairValueAdjustments	0	usd
CY2022Q4	xos	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1811000	usd
CY2021Q4	xos	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1092000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	188000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2747000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	415000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58705000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22808000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54572000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21530000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4133000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1278000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	998000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1278000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1770000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1365000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4133000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1278000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54600000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21500000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	283800000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-73325000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	23401000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-73325000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	23401000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	7350000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2022	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3267000	usd
CY2021	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-77408000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	23401000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165253000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105568000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165253000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105568000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174382000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107786000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22

Files In Submission

Name	View Source	Status
0001819493-23-000066-index-headers.html	Edgar Link	pending
0001819493-23-000066-index.html	Edgar Link	pending
0001819493-23-000066.txt	Edgar Link	pending
0001819493-23-000066-xbrl.zip	Edgar Link	pending
a202210-kexhibit211.htm	Edgar Link	pending
a202210-kexhibit231.htm	Edgar Link	pending
a202210-kexhibit232.htm	Edgar Link	pending
a202210-kexhibit311.htm	Edgar Link	pending
a202210-kexhibit312.htm	Edgar Link	pending
a202210-kexhibit321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xos-20221231.htm	Edgar Link	pending
xos-20221231.xsd	Edgar Link	pending
xos-20221231_g1.jpg	Edgar Link	pending
xos-20221231_g2.jpg	Edgar Link	pending
xos-20221231_g3.jpg	Edgar Link	pending
xos-20221231_g4.jpg	Edgar Link	pending
xos-20221231_cal.xml	Edgar Link	unprocessable
xos-20221231_def.xml	Edgar Link	unprocessable
xos-20221231_lab.xml	Edgar Link	unprocessable
xos-20221231_htm.xml	Edgar Link	completed
xos-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XOS
Xos, Inc. Stock $xos

2023 Q1 Form 10-K Financial Statement

#000181949323000066 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XOS Xos, Inc. Stock $xos

2023 Q1 Form 10-K Financial Statement

#000181949323000066 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XOS
Xos, Inc. Stock $xos